The Light of Life Foundation logo
  • Thyroid Cancer Awareness Month

    Thyroid Cancer Awareness Month

    Light of Life Foundation supports Thyroid Cancer Awareness Month in the month of September. Please help spread the word "CHECK YOUR NECK" for thyroid cancer. Early detection is the key to saving lives.

  • Delicious Low Iodine Recipes

    New LOL Updated Iodine Cookbook

    Thyroid Cancer diet restrictions don't mean the end of delicious food. Browse simple, healthy recipes created for patients, by patients in the Light of Life Low Iodine Cookbook.

  • Read real survival stories

    Read real survival stories

    There are over 350,000 Thyroid Cancer patients living in the US today, across every age group, gender and race. Read the real survival stories of people just like you--and submit your own.

  • You Are Not Alone

    You Are Not Alone

    Thousands of patients, caretakers, relatives and friends from all corners of the world have joined our Facebook support group to share experiences, get advice, and offer friendship online. Click here to chat now.

  • Cindy Crawford

    Cindy Crawford

    The Light of Life Foundation is proud to report Cindy Crawford has just done a PSA photo shoot for the Light of Life Foundation. We are in the process of developing a new awareness campaign. VERY EXCITING NEWS! More to come...please revisit our website soon for more details.

About the Foundation

The Light of Life Foundation was established in the spring of 1997 by Joan Shey, a patient herself. The mission of the foundation (a 501(c)(3) non-profit organization) is to improve the quality of life of thyroid cancer patients through continual education of the lay public and the medical community, and by promoting research and development to improve thyroid cancer care.


Light of Life Foundation Patient Educational Day
  • Memorial Sloan Kettering Cancer Center in New York City, Saturday, April 18th, 2015 8:30am-2:30pm.

View all events...


Thyrogen Revised to Include Use of Wider Range of Radioiodine in Patients

Revised label will facilitate use of Thyrogen to greater number of patients for postoperative thyroid remnant ablation

CAMBRIDGE, Mass. – Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the Food and Drug Administration (FDA) approved revised prescribing information for the use of Thyrogen® (thyrotropin alfa for injection) to widen the dose range of radioiodine (RAI) when used for thyroid remnant ablation. Thyrogen is used before radioiodine treatment to enhance uptake of the radiotracer and allows patients to start and continue taking their thyroid hormone replacement therapy thus avoiding the untoward effects associated with hypothyroidism. Previously the amount of radioiodine was fixed at 100 mCi, whereas physicians may now select a dose from the range of 30-100 mCi.

View all news...